Our preliminary studies have demonstrated a marked decrease in pertussis toxin-sensitive G-proteins in adipocytes from obese mice. Thus, a major objective is to see whether this phenomenon is a general feature of diabetes. This study will examine the hypothesis that expression and/or function of pertussis toxin (PTX) sensitive G-proteins in adipocytes form animal models of Type I and Type II diabetes are abnormal. Expression and function of PTX sensitive G-proteins will be assessed on cells from the two types of animals using the following strategy: a) Adipocyte membranes will be solubilized and the extract subjected to in vitro ADP-ribosylation with pertussis toxin and [32P]-NAD, followed by SDS-PAGE and autoradiography. The autoradiograms will be subjected to scanning laser densitometry to quantitate the resolved 40,000 and 41,000 kDa G-proteins in each phenotype. b) The relative amount of G-protein that is coupled to adenylate cyclase inhibition and an assessment of communication between the components of this pathway will be examined by comparing the ability of the GTP analogue, Gpp(NH)p, to inhibit forskolin-stimulated adenylate cyclase in membranes from each phenotype. c) Functioning of the inhibitory G-protein circuit from hormone receptor to effector system will be assessed in membranes from each phenotype by comparing the ability of phenylisopropyladenosine (PIA) to inhibit isoproterenol-stimulated adenylate cyclase, and in cells by comparing the ability of insulin to activate the particulate low Km phosphodiesterase (PDE). The significance of using PIA inhibition of cyclase and insulin activation of PDE is that the pathways are independent and both involve G-proteins which are pertussis toxin substrates. The present approach is unique in that functional assessments will test for changes in receptor-G protein interactions and G-protein-adenylate cyclase interactions. Overall, this study will assess whether changes in PTX- sensitive G-protein expression or function are involved in altered hormonal signalling in models of Type I and Type II diabetes. The long term goal of this work is to clarify the interrelationships among several events involved in the insulin signal transduction sequence in adipocytes and improve understanding of the pathophysiology of diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29DK042486-01
Application #
3464121
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1990-06-01
Project End
1995-05-31
Budget Start
1990-06-01
Budget End
1991-05-31
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Ramkumar, V; Ravi, R; Wilson, M C et al. (1994) Identification of A1 adenosine receptors in rat cochlea coupled to inhibition of adenylyl cyclase. Am J Physiol 267:C731-7
Mulheron, J G; Casanas, S J; Arthur, J M et al. (1994) Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s). J Biol Chem 269:12954-62
Gettys, T W; Fields, T A; Raymond, J R (1994) Selective activation of inhibitory G-protein alpha-subunits by partial agonists of the human 5-HT1A receptor. Biochemistry 33:4283-90
Palmer, T M; Gettys, T W; Jacobson, K A et al. (1994) Desensitization of the canine A2a adenosine receptor: delineation of multiple processes. Mol Pharmacol 45:1082-94
McGill, J M; Basavappa, S; Gettys, T W et al. (1994) Secretin activates Cl- channels in bile duct epithelial cells through a cAMP-dependent mechanism. Am J Physiol 266:G731-6
Raymond, J R; Arthur, J M; Casanas, S J et al. (1994) Alpha 2A adrenergic receptors inhibit cAMP accumulation in embryonic stem cells which lack Gi alpha 2. J Biol Chem 269:13073-5
Collins, S; Daniel, K W; Rohlfs, E M et al. (1994) Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8:518-27
Gettys, T W; Sheriff-Carter, K; Moomaw, J et al. (1994) Characterization and use of crude alpha-subunit preparations for quantitative immunoblotting of G proteins. Anal Biochem 220:82-91
Davies, M G; Ramkumar, V; Gettys, T W et al. (1994) The expression and function of G-proteins in experimental intimal hyperplasia. J Clin Invest 94:1680-9
Kineman, R D; Gettys, T W; Frawley, L S (1994) Paradoxical effects of dopamine (DA): Gi alpha 3 mediates DA inhibition of PRL release while masking its PRL-releasing activity. Endocrinology 135:790-3

Showing the most recent 10 out of 21 publications